Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-05T04:44:47.017Z Has data issue: false hasContentIssue false
  • English
  • Français

Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial – Expression of concern

Published online by Cambridge University Press:  06 August 2021

Fariba Raygan ,
Milad Behnejad ,
Vahidreza Ostadmohammadi ,
Fereshteh Bahmani ,
Mohammad A Mansournia ,
Fatemeh Karamali  and
Zatollah Asemi
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Expression of concern
Information
British Journal of Nutrition , Volume 127 , Issue 1 , 14 January 2022 , pp. 157
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Nutrition Society

The Editor-in-Chief has been alerted to concerns about the integrity of the above article and is investigating the claims. The concerns have also been referred to the Iranian National Committee for Ethics in Biomedical Research. This statement will be updated when both investigations have been completed and the authors have been given the opportunity to respond to the outcomes of those investigations.

References

Raygan, F., Behnejad, M., Ostadmohammadi, V., Bahmani, F., Mansournia, M., Karamali, F., & Asemi, Z. (2018) Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: A randomised, double-blind, placebo-controlled trial. British Journal of Nutrition, 120(1), 33–40.CrossRefGoogle ScholarPubMed